Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif

Science
P HenthornT Kadesch

Abstract

Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins. Two complementary DNAs were isolated that encode proteins, denoted ITF-1 and ITF-2, that are expressed in a variety of cell types and bind the microE5/kappa 2 motif found in both heavy and kappa light chain enhancers. The complementary DNAs are the products of distinct genes, yet both ITF-1 and ITF-2 are structurally and functionally similar. The two proteins interact with one another through their putative helix-loop-helix motifs and each possesses a distinct domain that dictates transcription activation.

References

Mar 2, 1989·Nature·J W Lillie, M R Green
Jan 1, 1988·Annual Review of Cell Biology·M L Atchison
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·P HenthornT Kadesch
Apr 1, 1973·Virology·F L Graham, A J van der Eb

❮ Previous
Next ❯

Citations

Nov 9, 2000·European Journal of Immunology·I BergqvistD Holmberg
Jun 1, 1995·Developmental Dynamics : an Official Publication of the American Association of Anatomists·W Ellmeier, A Weith
Mar 1, 1995·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·M A Rudnicki, R Jaenisch
Mar 1, 1992·Genes, Chromosomes & Cancer·C A GriffinR Mann
Mar 1, 1991·International Journal of Cell Cloning·K Takeshita, E J Benz
Dec 1, 1995·Leukemia Research·A IshiguroH P Koeffler
Jun 1, 1995·Brain Research. Molecular Brain Research·W ZhuM A Israel
Apr 1, 1994·Current Opinion in Immunology·J Hagman, R Grosschedl
Mar 8, 2000·Cancer Genetics and Cytogenetics·N HiraseJ Nishimura
Sep 27, 2000·Biochimica Et Biophysica Acta·B MitchellC Vierra
Jun 20, 1997·Molecular and Cellular Endocrinology·T NagasawaL J DeGroot
Nov 30, 2002·Seminars in Immunology·Stephen Greenbaum, Yuan Zhuang
Nov 25, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Robert A MoxleySuchareeta Mitra
Oct 21, 2009·Proceedings of the National Academy of Sciences of the United States of America·Sebastian J Maerkl, Stephen R Quake
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A Voronova, D Baltimore
May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·N KawaguchiM Noda
Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·L BrownR Baer
Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·Y ZhuangH Weintraub
May 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·V SartorelliL Kedes

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.